Financials

  • Market Capitalization 148.92 M
  • Employee 65
  • Founded 2007
  • CEO Niels C. Riedemann
  • Website www.inflarx.de
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Biotechnology

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3799
CNTB
Connect Biopharma Holdings Limited - American Depositary Shares
2.44 USD+3.39%+11.93%+18.45%+59.48%153.63 M USD
3810
HURA
TuHURA Biosciences, Inc. - Common Stock
2.30 USD-3.36%+5.99%+2.68%+0.44%146.47 M USD
3813
TLSA
Tiziana Life Sciences Ltd - Common Shares
1.15 USD-7.26%-6.50%+6.48%-20.69%138.58 M USD
3817
PYXS
Pyxis Oncology, Inc. - Common Stock
2.40 USD+4.80%-13.04%+37.93%+108.70%152.05 M USD

Frequently asked questions about InflaRx N.V. - Common Stock

What is the InflaRx N.V. - Common Stock stock price today?

The current price of InflaRx N.V. - Common Stock (IFRX) is 2.06. Over the past 24 hours, the stock has changed by +2.49%. Follow the IFRX chart for real-time price dynamics.

What is the stock ticker of InflaRx N.V. - Common Stock?

InflaRx N.V. - Common Stock trades under the ticker IFRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is InflaRx N.V. - Common Stock stock going up?

IFRX has changed by +0.98% over the last week, +26.38% over the last month, and +145.24% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does InflaRx N.V. - Common Stock have?

As of the latest available data, InflaRx N.V. - Common Stock has 65 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy InflaRx N.V. - Common Stock stock?

You can buy InflaRx N.V. - Common Stock (IFRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in InflaRx N.V. - Common Stock stock?

Investing in InflaRx N.V. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IFRX chart and related analysis on metatrader.com as part of your research.

News